Elisabeth Krones
Graz, 8036, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis.
Journal: Alimentary pharmacology & therapeutics
Published: August 14, 2020
FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis.
Journal: Journal of hepatology
Published: June 14, 2019
Clinical-Pathological Conference Series from the Medical University of Graz : Case No 161: A 42-year-old journalist with fatigue, elevated liver function tests, hyperglycemia and pruritus.
Journal: Wiener klinische Wochenschrift
Published: July 25, 2018
Downgrading of a G3 Neuroendocrine Tumor to a G2 Tumor: Can First-Line Cytotoxic Chemotherapy Change the Tumor Biology?
Journal: Case reports in oncology
Published: October 23, 2017
Ultrasound verified inflammation and structural damage in patients with hereditary haemochromatosis-related arthropathy.
Journal: Arthritis research & therapy
Published: July 18, 2017
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).
Journal: Wiener klinische Wochenschrift
Published: May 18, 2017
Cholemic nephropathy - Historical notes and novel perspectives.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: May 11, 2017
Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.
Journal: Gastroenterology report
Published: February 28, 2017
Genetic loss of the muscarinic M3 receptor markedly alters bile formation and cholestatic liver injury in mice.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 21, 2017
NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.
Journal: Journal of hepatology
Published: July 20, 2016
Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis.
Journal: Alimentary pharmacology & therapeutics
Published: June 16, 2016
Last Updated: 09/26/2026